Finerenone for treating heart failure with preserved or mildly reduced ejection fraction ID6514

  • In development
  • GID-TA11651
  • Expected publication date: TBC

Suggested remit: To appraise the clinical and cost effectiveness of Finerenone within its marketing authorisation for treating heart failure